KRS Capital Management’s Merck MRK Stock Holding History

KRS Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$389K	Buy	3,029 +19	+0.6%	+$2.22K	0.18%	85
2026 Q1	$362K	Buy	3,010 +3	+0.1%	+$346	0.22%	76
2025 Q4	$317K	Buy	3,007 +4	+0.1%	+$375	0.18%	89
2025 Q3	$252K	Sell	3,003 -73	-2%	-$6.01K	0.15%	100
2025 Q2	$244K	Sell	3,076 -253	-8%	-$20.1K	0.16%	96
2025 Q1	$299K	Sell	3,329 -307	-8%	-$28.7K	0.24%	83
2024 Q4	$362K	Sell	3,636 -893	-20%	-$92.1K	0.26%	77
2024 Q3	$514K	Sell	4,529 -364	-7%	-$43.2K	0.38%	62
2024 Q2	$606K	Buy	4,893 +54	+1%	+$6.96K	0.45%	47
2024 Q1	$639K	Sell	4,839 -219	-4%	-$27K	0.52%	45
2023 Q4	$551K	Sell	5,058 -302	-6%	-$31.3K	0.51%	55
2023 Q3	$552K	Buy	5,360 +37	+0.7%	+$3.99K	0.59%	49
2023 Q2	$614K	Buy	5,323 +199	+4%	+$22.6K	0.61%	46
2023 Q1	$545K	Buy	5,124 +772	+18%	+$83.3K	0.61%	46
2022 Q4	$483K	Buy	+4,352	New	+$445K	0.66%	46

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

KRS Capital Management's MRK Position: Q2 2026 in Review

KRS Capital Management increased its Merck (MRK) stake by 0.63% in Q2 2026, buying an estimated $2.22K and bringing the position to 3,029 shares worth $389K. The position accounts for 0.18% of the portfolio, ranked #85.

KRS Capital Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $639K in Q1 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

KRS Capital Management held 3,029 shares of Merck worth $389K as of Q2 2026.
KRS Capital Management bought 19 Merck shares in Q2 2026, an estimated $2.22K.
Merck made up 0.18% of KRS Capital Management's portfolio in Q2 2026, its #85 holding.
KRS Capital Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
KRS Capital Management's Merck position peaked at $639K in Q1 2024.
1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on KRS Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.